Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China.
Chengdu Xinan Gynecology Hospital, Chengdu, China.
BMJ Open. 2024 Aug 19;14(8):e081098. doi: 10.1136/bmjopen-2023-081098.
The therapeutic needs of women with diminished ovarian reserve (DOR), coupled with the increasing application of acupuncture in improving ovarian function, have highlighted the need to verify the efficacy and safety of acupuncture for DOR. This study aims to provide high-quality evidence by evaluating both ovarian reserve and in vitro fertilisation (IVF) outcomes.
A large-scale, multicentre, randomised controlled trial will be carried out across seven hospitals in China. 400 women with DOR will be randomised in a 1:1 ratio to an acupuncture group or a sham acupuncture group. Acupuncture or sham acupuncture will consist of 36 sessions per participant over 12 weeks. The primary outcome will be the change in antral follicle count (AFC) at week 12 from baseline. Secondary outcomes are AFC at week 24, the serum levels of basal follicle-stimulating hormone and anti-Mullerian hormone at weeks 12 and 24, the scores of the Self-Rating Anxiety Scale at weeks 12 and 24, clinical pregnancy rate, and IVF embryo transfer related outcomes. Any adverse events during treatment will be documented.
The study protocol has been approved by all the participating institutions. Written informed consent will be obtained prior to participant enrolment. The results of this study will be published in peer-reviewed publications.
ChiCTR2200062295 PROTOCOL VERSION: V2.0-20220317.
患有卵巢储备功能减退(DOR)的女性的治疗需求,加上针灸在改善卵巢功能方面的应用不断增加,这使得验证针灸对 DOR 的疗效和安全性变得尤为重要。本研究旨在通过评估卵巢储备和体外受精(IVF)结局,提供高质量的证据。
这是一项在中国 7 家医院开展的大规模、多中心、随机对照试验。将 400 名 DOR 患者按照 1:1 的比例随机分为针灸组或假针灸组。每个参与者接受 36 次针灸或假针灸治疗,共 12 周。主要结局是从基线到第 12 周时窦卵泡计数(AFC)的变化。次要结局是第 24 周时的 AFC、第 12 周和第 24 周时基础卵泡刺激素和抗苗勒管激素的血清水平、第 12 周和第 24 周时的自我评定焦虑量表评分、临床妊娠率以及 IVF 胚胎移植相关结局。记录治疗期间的任何不良事件。
该研究方案已获得所有参与机构的批准。在参与者入组前将获得书面知情同意。本研究的结果将发表在同行评议的出版物上。
ChiCTR2200062295 方案版本:V2.0-20220317。